Skip to main content
OpenTrials

Clinical trial condition

Overactive Bladder

Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.

362 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Overactive Bladder trial results

Completed

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

NCT02601287

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Pusan National University Hospital Busan, Korea, South Korea
  • The Catholic University of Korea Bucheion St. Mary Hospital Gyeonggi-do, Korea, South Korea
  • Seoul National University Hospital Seoul, Korea, South Korea
  • Asan Medical Center Seoul, Korea, South Korea
View Trial Details
Completed

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

NCT00685113

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Duramed Investigational Site Huntsville, Alabama, United States
  • Duramed Investigational Site Mobile, Alabama, United States
  • Duramed Investigational Site Montgomery, Alabama, United States
  • Duramed Investigational Site Phoenix, Arizona, United States
View all 84 locations
View Trial Details
Completed

SSR240600C Treatment in Women With Overactive Bladder

NCT00564226

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations
  • Sanofi-Aventis Aministrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Laval, Quebec, Canada
  • Sanofi-Aventis Administrative Office Prague, Czechia
  • Sanofi-Aventis Administrative Office Paris, France
View Trial Details

Related conditions